Search Results

Non-physician delivered intravitreal injection service is feasible and safe - a systematic review.

• Authors : Rasul A; .; Subhi Y

Subjects: Intravitreal Injections/Intravitreal Injections/Intravitreal Injections/*nursing ; Ophthalmology/Ophthalmology/Ophthalmology/*education ; Retinal Diseases/Retinal Diseases/Retinal Diseases/*drug therapy

• Source: Danish medical journal [Dan Med J] 2016 May; Vol. 63 (5).Publisher: Danish Medical Association Country of Publication: Denmark NLM ID: 101576205 Publication Model: Print Cited Medium: Internet ISSN:

Record details

LOOKING AHEAD: 2024 IS SHAPING UP TO BE AN INTERESTING YEAR.

• Authors : Mali, Joshua^1,2

Subjects: *THERAPEUTIC use of monoclonal antibodies; *VASCULAR endothelial growth factors; *OPHTHALMOLOGISTSUNITED States. Food & Drug Administration

• Source: Ophthalmology Times. Jan2024, Vol. 49 Issue 1, p31-31. 1p.

Record details

Short-term Effects of Intravitreal Dexamethasone Implant on Choroidal Structure in Eyes with Refractory Diabetic Macular Edema.

• Authors : Bilici, Serdar; Serbest, Enes; Ugurbas, Suat Hayri

Subjects: DEXAMETHASONE; MACULAR edema; VASCULAR endothelial growth factors

• Source: Beyoglu Eye Journal; 2023, Vol. 8 Issue 3, p193-197, 5p

Record details

Retinal Ven Tıkanıklığına Sekonder Gelişen ve İntravitreal Ranibizumab Enjeksiyonuna Dirençli Maküler Ödemin Tedavisinde İntravitreal Deksametazon İmplantının Etkinliği.

• Authors : Ergin, Ayşe; Açıkalın, Banu; Kurna, Sevda Aydın

Subjects: DRUG efficacy; MACULAR edema; INTRAOCULAR pressure

• Source: Bosphorus Medical Journal / Boğaziçi Tıp Dergisi; 2022, Vol. 9 Issue 4, p253-261, 9p

Record details

INTRAVITREAL BEVACIZUMAB ALONE VERSUS INTRAVITREAL BEVACIZUMAB IN COMBINATION WITH FOCAL MACULAR PHOTOCOAGULATION IN DIABETIC MACULAR OEDEMA.

• Authors : Jatoi, Asad Ullah; Shaikh, Noman Ahmed; Narsan, Ashok Kumar

Subjects: BEVACIZUMAB; LIGHT coagulation; EDEMA

• Source: Journal of Ayub Medical College Abbottabad - Pakistan; Jan-Mar2022, Vol. 34 Issue 1, p160-163, 4p

Record details

Patent Issued for Pharmaceutical composition (USPTO 11951103).

Subjects: DIABETIC retinopathy; RETINAL vein occlusion; MACULAR degeneration

• Source: Cardiovascular Week; 4/29/2024, p1428-1428, 1p

Record details

New Findings from Yamaguchi University Graduate School of Medicine in the Area of Retinal Hemorrhage Described (Exacerbation of Diabetic Retinopathy following Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Administration: A Case Report).

Subjects: DIABETIC retinopathy; COLLEGE graduates; GRADUATE education

• Source: Hematology Week; 4/18/2024, p259-259, 1p

Record details

Researchers from Aviation General Hospital Detail Findings in Diabetic Retinopathy (The Effect of Curcumin On Intravitreal Proinflammatory Cytokines, Oxidative Stress Markers, and Vascular Endothelial Growth Factor In an Experimental Model of...).

Subjects: VASCULAR endothelial growth factors; DIABETIC retinopathy; OXIDATIVE stressBEIJING (China)

• Source: Diabetes Week; 4/8/2024, p294-294, 1p

Record details

Patent Application Titled "Dendrimer Compositions And Methods For Drug Delivery To The Eye" Published Online (USPTO 20240058459).

Subjects: PATENT applications; VASCULAR endothelial growth factors; INTERNET publishing

• Source: Pharma Business Week; 3/12/2024, p638-638, 1p

Record details

Grewal Eye Institute Researcher Reports on Findings in Diabetic Retinopathy (Outcomes of intravitreal anti-VEGF injections and panretinal photocoagulation in preretinal hemorrhage secondary to proliferative diabetic retinopathy involving the...).

Subjects: DIABETIC retinopathy; INTRAVITREAL injections; LIGHT coagulation

• Source: Diabetes Week; 3/11/2024, p293-293, 1p

Record details